Research Article
Clinical, Histopathological, and Prognostic Characteristics of Patients with Prostate Cancer in Lubumbashi, Democratic Republic of Congo
Table 3
Characteristics of the patients according to their outcomes.
| | Variable | Survived (n = 50) | Deceased (n = 24) | Lost to follow-up (n = 14) | value |
| | Age (in years) | | | | | | Mean (range) | 68.48 (49–90) | 68.79 (47–83) | 69.57 (60–80) | 0.905 |
| | PSA level at diagnosis (in ng/ml) | | | | | | Mean (range) | 80.38 (6.5–89.32) | 268.35 (9–1564.50) | 93.53 (4–251.00) | 0.007 |
| | PSA level at 3 months of follow-up (in ng/ml) | | | | | | Mean (range) | 28.44 (0.16–87.12) | 357.66 (88.13–1782.10) | 73.39 (0.23–201.16) | <0.0001 |
| | Comorbidity | | | | 0.6966 | | Present | 14 (28.00%) | 9 (37.50%) | 4 (28.57%) | | | Absent | 36 (72.00%) | 15 (62.50%) | 10 (71.43%) | |
| | Prostate on digital rectal examination | | | | 0.0013 | | Normal | 35 (70.00%) | 6 (25.00%) | 8 (57.14%) | | | Abnormal | 15 (30.00%) | 18 (75.00%) | 6 (42.86%) | |
| | D’Amico risk classification | | | | 0.1163 | | Low risk | 12 (24.00%) | 4 (16.67%) | 2 (14.29%) | | | Intermediate risk | 13 (26.00%) | 1 (4.17%) | 4 (28.57%) | | | High risk | 25 (50.00%) | 19 (79.17%) | 8 (57.14%) | |
| | Gleason score | | | | 0.0513 | | <7 | 19 (38.00%) | 3 (12.50%) | 4 (28.57%) | | | 7 | 19 (38.00%) | 8 (33.33%) | 7 (50.00%) | | | >7 | 12 (24.00%) | 13 (54.17%) | 3 (21.43%) | |
|
|
